 |
市場調查報告書
商品編碼
2125757
市場狀況：定序Market Landscape: Sequencing |
||||||
市場規模、廠商市場佔有率及至2030年的五年預測
定序已從一種專門的研究方法發展成為生命科學研究、臨床試驗、藥物和生物技術研發以及許多其他領域的基礎性基礎設施。大規模讀取核酸序列的能力是全球基礎研究、藥物發現、診斷和公共衛生計畫的基礎。在數十年技術進步的推動下，定序工具和應用正在快速發展，並不斷擴展基因組分析的能力和可能性。
「市場概況—定序報告」為那些在競爭激烈的科研定序市場中摸索前行的人士提供了詳盡的資訊來源。定序是分析實驗室設備領域中最具盈利的技術之一。其發展歷程不僅包含科學進步的創新與成功，也伴隨著許多法律糾紛和地緣政治因素。了解影響市場及其參與者的法規和訴訟對於理解市場現狀和發展方向至關重要。
對於對定序市場感興趣的策略規劃人員、產品和行銷經理、業務發展團隊和投資者而言，這份報告將是寶貴的資訊來源。
本報告的主要特點如下：
- 近期及正在進行的訴訟、法規和市場動態的詳細清單。
- 對定序市場整體進行分析（包括按產品類型、地區、終端市場和功能分類的市場規模，以及未來 5 年的預測）
- 供應商市佔率分析
- 主要供應商分析（包括技術概述、關鍵業務趨勢以及按產品類型、地區和終端市場分類的銷售分析）
- Illumina
- MGI Tech
- Oxford Nanopore
- Pacific Biosciences
- Thermo Fisher Scientific
- 近期市場參與企業概況：
- Element Biosciences
- Roche
- Ultima Genomics
Market Sizing, Vendor Share, and 5-Year Forecasts Through 2030
Sequencing has moved from a specialized research technique to foundational infrastructure across life science research, clinical testing, pharma/bio R&D, and many other fields. The ability to read nucleic acid sequences at scale underpins basic discovery, drug development, diagnostics, and population health programs worldwide. The tools and applications for sequencing have advanced rapidly, shaped by technologies that have evolved over decades, which continue to expand the capabilities and possibilities of genomic analysis.
The Market Landscape: Sequencing Report provides an in-depth resource for those navigating the highly competitive market for research-use sequencing. Sequencing represents one of the highest revenue techniques of the analytical laboratory instrumentation space. Its history is filled not only with innovation and triumphs in scientific advancements, but also with legal battles and geopolitics. To understand the state and direction of the market, it is important to understand the regulations and litigation that shape the market and its participants.
This report is valuable for strategic planners, product and marketing managers, business development teams, and investors with an interest in the sequencing market.
Key features of this report include:
- Detailed lists of recent & ongoing litigation, regulations, and market developments
- Analysis of the overall sequencing market, including segmented market sizing and 5-year forecasts by product type, region, end market, and function
- Analysis of vendor market shares
- Analysis of key vendors, including technology overviews, key business developments, and analyses of revenues segmented by product types, regions, and end markets
- Illumina
- MGI Tech
- Oxford Nanopore
- Pacific Biosciences
- Thermo Fisher Scientific
- Profiles of recent market entrants:
- Element Biosciences
- Roche
- Ultima Genomics
